Iterum Therapeutics plc announced that, due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 34,782,609 ordinary shares at a public offering price of $1.15 per share, less underwriting discounts and commissions.
February 3, 2021
· 6 min read
